ALLERGAN PLC (NYSE:AGN) Files An 8-K Regulation FD Disclosure
Item7.01
| Regulation FD Disclosure. |
On December 2, 2016, Allergan plc issued a press release
providing an update on its Accelerated Share Repurchase Program.
A copy of the press release is attached hereto as Exhibit 99.1
and is incorporated by reference herein.
The information in this report (including the exhibit) is
furnished to Item7.01 and shall not be deemed to be filed for
purposes of Section18 of the Securities Exchange Act of 1934 (the
Exchange Act), nor shall it be deemed incorporated by reference
in any filing under the Securities Act of 1933 or the Exchange
Act, except as shall be expressly set forth by specific reference
in such filing.
| Item9.01 | Financial Statements and Exhibits. |
d. Exhibits:
| 99.1 |
Press Release of Allergan plc entitled Allergan Provides Update on Accelerated Share Repurchase (ASR) Program dated December 2, 2016. |
About ALLERGAN PLC (NYSE:AGN)
ALLERGAN PLC (NYSE:AGN) Recent Trading Information
ALLERGAN PLC (NYSE:AGN) closed its last trading session down -3.93 at 190.37 with 5,002,551 shares trading hands.